Members |
targetComponentId |
Benzoyl peroxide + sulfur 10%ww/5%ww |
Product containing benzoyl peroxide and sulfur (medicinal product) |
Benzoyl peroxide + sulfur 5%ww/2%ww |
Product containing benzoyl peroxide and sulfur (medicinal product) |
Benzoyl peroxide 10% |
Product containing benzoyl peroxide (medicinal product) |
Benzoyl peroxide 10% wash |
Product containing only benzoyl peroxide in cutaneous dose form (medicinal product form) |
Benzoyl peroxide 2.5% + clindamycin 1.2% topical gel |
Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Benzoyl peroxide 8% cream |
Product containing only benzoyl peroxide in cutaneous dose form (medicinal product form) |
Benzoyl peroxide 8% cutaneous cream |
Product containing only benzoyl peroxide in cutaneous dose form (medicinal product form) |
Benzquinamide 50mg injection solution vial |
Benzquinamide 25 mg/mL solution for injection |
Benzyl penicilloyl-polylysin 0.06mcm/.25mL |
Product containing only benzylpenicilloyl polylysine in parenteral dose form (medicinal product form) |
Benzyl penicilloyl-polylysin 0.06mmo injection |
Product containing only benzylpenicilloyl polylysine in parenteral dose form (medicinal product form) |
Benzyl penicilloyl-polylysin 0.06mmo/0.25mL injection |
Product containing only benzylpenicilloyl polylysine in parenteral dose form (medicinal product form) |
Benzyl penicilloyl-polylysin 0.06mmo/0.25mL injection solution 0.25mL syringe |
Product containing only benzylpenicilloyl polylysine in parenteral dose form (medicinal product form) |
Beractant 100mg intratracheal suspension 4mL vial |
Product containing precisely phospholipid (as beractant) 25 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug) |
Betaherpesvirus group |
Subfamily Betaherpesvirinae (organism) |
Betaine, anhydrous 1g/scp powder |
Betaine only product |
Betamethasone 0.1% cream |
Betamethasone valerate 1 mg/mL cutaneous cream |
Betamethasone 0.1% lotion |
Product containing precisely betamethasone valerate 1 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Betamethasone 0.1% ointment |
Product containing precisely betamethasone valerate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Betamethasone 0.6mg/5mL syrup |
Betamethasone 120 microgram/mL oral solution |
Betamethasone 500micrograms soluble tablet |
Betamethasone 500 microgram orodispersible tablet |
Betamethasone acetate + betamethasone sodium phospha 3mg/ns soluspan |
Product containing only betamethasone in parenteral dose form (medicinal product form) |
Betamethasone acetate + betamethasone sodium phosphate 3mg/3mg per mL injection suspension |
Product containing only betamethasone in parenteral dose form (medicinal product form) |
Betamethasone dipropionate + clotrimazole 0.64mg/10mg cream |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Betamethasone dipropionate 0.05% gel |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Betamethasone dipropionate 0.05% lotion |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Betamethasone dipropionate 0.5% ointment |
Betamethasone (as betamethasone dipropionate) 5 mg/g cutaneous ointment |
Betamethasone dipropionate 0.5mg cream |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
Betamethasone dipropionate 0.5mg/g cream |
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous cream |
Betamethasone dipropionate 0.5mg/g ointment |
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous ointment |
Betamethasone+clotrimazole 0.05/1% cream |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Betaxolol 0.25% conventional release eye drops |
Betaxolol (as betaxolol hydrochloride) 2.5 mg/mL eye drops |
Betaxolol 0.25% single-use eye drops |
Betaxolol (as betaxolol hydrochloride) 2.5 mg/mL eye drops |
Bi-layered skin substitute 75millimeter diameter circular disk |
A manufactured skin graft consisting of an outer epidermal layer and/or a dermal layer embedded into an acellular matrix or dermal template forming a biological skin substitute either grown from the patient's own cells, or from other allogeneic or xenogeneic sources, and/or synthetic materials, for example, silicone graft, or combined sources. |
Bi-layered skin substitute from keratinocytes and fibroblasts |
Bi-layered skin substitute from keratinocytes and fibroblasts (substance) |
Bicaulus |
Varestrongylus |
Bicaulus schulzi |
Varestrongylus |
Bicipital groove X-ray |
Plain X-ray of bicipital groove |
Bicornuate uterus affecting obstetric care |
Bicornuate uterus in pregnancy, childbirth and the puerperium |
Bifidobacterium suis |
Bifidobacterium longum |
Big big gastrin |
Gastrin-71 |
Biguanide oral hypoglycemic agent |
Biguanide hypoglycemic agent |
Bilateral complete and incomplete cleft lip and/or alveolus |
Congenital anomaly of mouth |
Bilateral femoral hernia with obstruction but no gangrene |
Obstructed bilateral femoral hernia (disorder) |
Bilateral hyperplasia |
Hyperplasia |
Bilateral hypoplasia |
Hypoplasia |
Bilateral right-sidedness sequence |
A rare heterotaxia characterised by complex congenital heart malformations and abnormal lateralisation of other thoracic and abdominal organs due to embryonic disruption of the left-right axis development. Cardiac defects include dextrocardia or mesocardia, common atrioventricular valve associated with complete atrioventricular septal defect or common atrium, transposition or malposition of the great arteries, and total anomalous pulmonary venous drainage, among others. Cardiac arrhythmias are frequently observed. Typical abnormalities of other organs are bilateral trilobed lungs, midline liver, and asplenia. Patients present in the newborn period with severe cardiac failure and cyanosis. Prognosis is poor. |
Bilateral traumatic amputation of arms at any level with complication |
Bilateral traumatic amputation of upper limbs (disorder) |
Bilateral traumatic amputation of arms at any level without complication |
Bilateral traumatic amputation of upper limbs (disorder) |
Bilateral traumatic amputation of feet with complication |
Traumatic amputation of both feet |
Bilateral traumatic amputation of feet without complication |
Traumatic amputation of both feet |
Bilateral traumatic amputation of legs at any level with complication |
Bilateral traumatic amputation of lower limbs (disorder) |
Bilateral traumatic amputation of legs at any level without complication |
Bilateral traumatic amputation of lower limbs (disorder) |
Bile agent adverse reaction |
Adverse reaction to bile acid and/or bile acid derivative (disorder) |
Bile duct calculus NOS |
Calculus of bile duct |
Bile duct calculus NOS |
Calculus of bile duct |
Bile duct calculus with acute cholecystitis and no obstruction |
Bile duct calculus with acute cholecystitis |
Biliary contr.radiog. normal |
Plain X-ray of biliary tract with contrast normal |
Biliary contr.radiog.abnormal |
Plain X-ray of biliary tract with contrast abnormal (finding) |
Biliary contr.radiog.requested |
Plain X-ray of biliary tract with contrast requested (situation) |
Biliary contrast radiography |
Plain X-ray of biliary tract with contrast (procedure) |
Biliary contrast radiography NOS |
Plain X-ray of biliary tract with contrast (procedure) |
Biliary contrast radiography NOS |
Plain X-ray of biliary tract with contrast (procedure) |
Biliary contrast radiography abnormal |
Plain X-ray of biliary tract with contrast abnormal (finding) |
Biliary contrast radiography normal |
Plain X-ray of biliary tract with contrast normal |
Biliary tract X-ray |
Plain X-ray of biliary tract |
Biliary tract anastomosis NOS |
Anastomosis of bile ducts |
Biliary tract anastomosis NOS |
Anastomosis of bile ducts |
Biliary tract disorders NOS |
Disorder of biliary tract |
Biliary tract disorders NOS |
Disorder of biliary tract |
Bililite therapy with ultraviolet light |
Light therapy |
Biocide in cosmetic |
Biocide |
Biological agent therapy for malignant disease |
Immunological therapy |
Biological scientist NOS |
Biological scientists and biochemists |
Biological scientist NOS |
Biological scientists and biochemists |
Biopsy of lesion of organ NOC |
Removal of tissue for diagnostic examination. |
Biopsy of lesion of unspecified organ |
Removal of tissue for diagnostic examination. |
Biopsy of lesion of wall of heart |
Biopsy of lesion of wall of heart (procedure) |
Biopsy of organ NOC |
Removal of tissue for diagnostic examination. |
Biopsy of organ NOC NOS |
Removal of tissue for diagnostic examination. |
Biopsy of unspecified body site |
Removal of tissue for diagnostic examination. |
Bird respiratory therapy |
Respiratory therapy |
Birnavirus |
Family Birnaviridae (organism) |
Birth details NOS |
Birth details - finding |
Birth details NOS |
Birth detail |
Birth dislocation of the shoulder |
Dislocation of glenohumeral joint due to birth trauma |
Birth head circumference NOS |
Birth head circumference |
Birth injury NOS |
Fetal birth trauma (disorder) |
Birth injury NOS |
Fetal birth trauma (disorder) |
Bisacodyl 5mg pediatric suppository |
Bisacodyl 5 mg rectal suppository |
Bison X Bos taurus taurus |
Bison bison X Bos taurus hybrid (organism) |
Bison bison |
Bison bison (organism) |
Bisoprolol fumarate + hydrochlorothiazide |
Product containing bisoprolol and hydrochlorothiazide (medicinal product) |
Bitolterol mesylate 0.2% solution |
Product containing only bitolterol (medicinal product) |
Bitolterol mesylate 0.2mg/mL solution |
Product containing only bitolterol (medicinal product) |
Bivalving of cast |
Bivalving of cast |
Black feces symptom |
Black faeces |
Bladder assessment observations |
Urinary bladder test feature (observable entity) |
Bladder contents evacuation NOS |
Drainage of urinary bladder (procedure) |
Bladder contents evacuation NOS |
Drainage of urinary bladder (procedure) |
Bladder disorders NOS |
Disorder of urinary bladder (disorder) |
Bladder disorders NOS |
Disorder of urinary bladder (disorder) |